1型糖尿病遗传学联盟
1型糖尿病由自身免疫破坏产胰岛素β细胞所致,遗传因素约占风险50%。2002年成立的1型糖尿病遗传学联盟(T1DGC)通过家系连锁分析和病例对照全基因组关联设计开展大规模遗传研究,发现超过100个与1型糖尿病风险相关的位点,数据与样本已向科学界开放。
要点
- T1DGC于2002年成立,由NIDDK资助,整合患病同胞对家系数据与样本并建立新收集。
- T1DGC采用家系连锁分析和病例对照全基因组关联设计开展大规模遗传研究。
- T1DGC发现超过100个与1型糖尿病风险相关的位点,并鉴定疾病相关细胞类型中的非编码遗传变异。
核心结论
- T1DGC扩展了1型糖尿病风险基因列表,并鉴定出疾病相关细胞类型中参与病因的非编码遗传变异。
- T1DGC的数据、结果和样本已向科学界开放,持续影响将遗传变异映射至功能及识别预测、预防和治疗新靶点通路。
研究设计与样本
- T1DGC于2002年成立,获NIDDK资助,整合患病同胞对家系已有数据与样本并建立新收集。
- T1DGC采用家系设计(用于连锁分析)和病例对照设计(用于全基因组关联分析)开展大规模遗传研究,并使用精细定位界定风险区域。
主要发现
- T1DGC发现超过100个与1型糖尿病风险相关的位点,许多位点效应较小且与自身免疫通路相关。
- T1DGC鉴定出疾病相关细胞类型中参与1型糖尿病病因的非编码遗传变异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Type 1 diabetes (T1D) results from the autoimmune destruction of the insulin-producing β cells. Genetic factors account for approximately 50% of the risk for T1D but, by the late 1990s, the genetic basis was limited. The Type 1 Diabetes Genetics Consortium (T1DGC) was formed in 2002 to accelerate discovery of genes contributing to T1D risk through a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to assemble existing data and samples from affected sib-pair families and to establish new collections. In recognition of the 75th anniversary of the NIDDK, this manuscript highlights the contributions made by the T1DGC to understanding the genetic basis of T1D using both family (for linkage) and case-control (for genome-wide association) designs. The T1DGC conducted large-scale genetic research and used fine mapping to define risk regions. The T1DGC data, results, and samples have been made available to the scientific community, leading to the discovery of more than 100 loci associated with T1D risk, many with small effects and relevant to autoimmune pathways. The T1DGC not only expanded the list of genes contributing to disease risk but also identified noncoding genetic variation in disease-relevant cell types that contribute to the etiology of T1D. The success of the T1DGC and the NIDDK investment in the global consortium is highlighted in its continuing effect on mapping genetic variants to their function and identifying pathways that provide new targets for the prediction, prevention, and treatment of T1D.
引用
- Onengut-Gumuscu S, Concannon P, Akolkar B, et al. Type 1 Diabetes Genetics Consortium. J Clin Endocrinol Metab. 2025. PMID: 40117445. doi:10.1210/clinem/dgaf181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。